Prescription Opioid Use in Patients With and Without Systemic Lupus Erythematosus — Michigan Lupus Epidemiology and Surveillance Program, 2014–2015 | MMWR

Prescription Opioid Use in Patients With and Without Systemic Lupus Erythematosus — Michigan Lupus Epidemiology and Surveillance Program, 2014–2015 | MMWR

MMWR Weekly (No. 38)
PDF of Weekly issue

Prescription Opioid Use in Patients With and Without Systemic Lupus Erythematosus — Michigan Lupus Epidemiology and Surveillance Program, 2014–2015

Weekly / September 27, 2019 / 68(38);819–824

Emily C. Somers, PhD1,2,3; Jiha Lee, MD1; Afton L. Hassett, PsyD4; Suzanna M. Zick, ND5; Siobán D. Harlow, PhD6; Charles G. Helmick, MD7; Kamil E. Barbour, PhD7; Caroline Gordon, MD8; Chad M. Brummett, MD4; Deeba Minhas, MD1; Amrita Padda, MD1; Lu Wang, PhD9; W. Joseph McCune, MD1; Wendy Marder, MD1,3 (View author affiliations)

Nearly one in three Michigan patients with lupus used prescription opioids for pain, despite lack of evidence that opioids help.